Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis for Fortune.
Page 41 of 73
Features
Verizon’s pay TV plan, and finance bigwigs meet in Washington — 5 things to know today
By
Laura Lorenzetti
Features
Bernanke’s new gig, and Mattel tries to save Barbie — 5 things to know today
By
Laura Lorenzetti
Tech
Benchling wants to become the Salesforce of biotech
By
Laura Lorenzetti
Features
These are the 5 cruise lines with the most stomach bug outbreaks
By
Laura Lorenzetti
Features
Google hit with EU antitrust charge, and Etsy prices its IPO — 5 things to know today
By
Laura Lorenzetti
Features
The Roundup problem: Why it’s so hard to pinpoint what causes cancer
By
Laura Lorenzetti
Features
Nokia eyes Alcatel-Lucent, and IBM jumps into healthcare — 5 things to know today
By
Laura Lorenzetti
Features
Apple Watch sales, and the U.S. presidential pool takes shape — 5 things to know today
By
Laura Lorenzetti
Features
Listeria hysteria: Here’s what foods are affected, and why
By
Laura Lorenzetti
Finance
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal
By
Laura Lorenzetti
Finance
Mylan goes big with $29 billion offer to buy Perrigo
By
Laura Lorenzetti
Features
Shell’s $70 billion mega-deal, and a Fed update — 5 things to know today
By
Laura Lorenzetti
Features
FedEx buys TNT, and Rand Paul to declare presidential bid — 5 things to know today
By
Laura Lorenzetti
Features
Greece ready to pay and Furious 7 breaks records — 5 things to know today
By
Laura Lorenzetti
International
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By
Laura Lorenzetti